Neuropeptide Y receptors as targets of obesity treatment

Author： Ishihara PhD Akane   Moriya PhD Minoru   MacNeil PhD Douglas J   Fukami PhD Takehiro   Kanatani PhD Akio  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.12, 2006-12, pp. : 1701-1712

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status

By Parker E.   Van Heek M.   Stamford A.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 173-187

Elsevier

Access to resources Recommend Favorite

Melanocortin Receptors as Targets in the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1098-1110

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptide Y receptor antagonists in obesity

By Gehlert D.R.   Hipskind P.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1827-1838

Informa Healthcare

Access to resources Recommend Favorite

Editorial [ Neuropeptide Y Receptors as Targets in Drug Discovery Guest Editor: Ambikaipakan Balasubramaniam ]

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 17, 2007-09 ,pp. : 1644-1644

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptide Y Y 1 receptors in vascular pharmacology

By Franco-Cereceda A.   Liska J.  

European Journal of Pharmacology, Vol. 349, Iss. 1, 1998-05 ,pp. : 1-14

Elsevier

Access to resources Recommend Favorite